This means that our former runner-up here, PureBulk, is the undisputed top pick in our estimation
However, they highlighted the limited evidence of similar effects in humans and called for longer-term trials to clarify the potential risks [134]
Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]
Tsai J-C, Perrella MA, Yoshizumi M, Hsieh C-M, Haber E, Schlegel R, and Lee M-E (1994)
In this group, 9% used the medications specifically to treat a chronic condition such as heart disease or diabetes, the highest rate of medical use across all age groups
Nutritional Gaps Reduced appetite is common during treatment